Mechanism Study of Itraconazole in Acute Myeloid Leukemia
Itraconazole (ITRA) is a broad-spectrum anti-fungal agent approved by the Food and Drug Administration (FDA). It has been shown to inhibit cancer growth, but the underlying molecular mechanism of itraconazole-induced cell death in acute myeloid leukemia (AML) remains largely elusive.